Comparison of Current International Guidelines for the Management of Dyslipidemia

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

(2022) Michelle L. O’Donoghue et al.   CIRCULATION

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

(2022) Donald M. Lloyd-Jones et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Taking action: European Atherosclerosis Society targets the United Nations Sustainable Development Goals 2030 agenda to fight atherosclerotic cardiovascular disease in Europe

(2021) Paolo Parini et al.   ATHEROSCLEROSIS

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2021) Glen J. Pearson et al.   CANADIAN JOURNAL OF CARDIOLOGY

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

(2021) Frank L J Visseren et al.   EUROPEAN HEART JOURNAL

Redefining cardiovascular risk prediction: is the crystal ball clearer now?

(2021) Lale Tokgozoglu et al.   EUROPEAN HEART JOURNAL

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia

(2021) Salim S. Virani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association

(2021) Andrew P. Landstrom et al.   Circulation-Genomic and Precision Medicine

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

Colchicine in Patients with Chronic Coronary Disease

(2020) Stefan M. Nidorf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations

(2020) Carl E. Orringer et al.   Journal of the American Heart Association

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

(2019) Guy De Backer et al.   ATHEROSCLEROSIS

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia

(2019) Mary P. McGowan et al.   Journal of the American Heart Association

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective

(2016) Fleur M. van der Valk et al.   CIRCULATION

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

(2015) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

(2013) Pia R. Kamstrup et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: Comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects

(2012) Takashi Miida et al.   ATHEROSCLEROSIS

A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

(2011) Allan D. Sniderman et al.  

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(2009) Kornelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION